Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTNJYV2)

• DTT Name: Gamma-aminobutyric acid receptor (GAR)
• Gene Name: GAR
• DTT Type: Successful target; [1]
• UniProt ID: NOUNIPROTAC
• TTD ID: T64382

Molecular Interaction Atlas (MIA) of This DTT

8 Approved Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Allopregnanolone	DMNLHAC	Depression	6A70-6A7Z	approved	[2]
Alpidem	DMN7Y9K	Anxiety disorder	6B00-6B0Z	Approved	[3]
Clonazepam	DMTO13J	Absence epilepsy		Approved	[1]
DP-VPA	DMGOXPQ	Bipolar disorder	6A60	Approved	[4]
Moxidectin	DMYGHX5	Onchocerciasis	1F6A	Approved	[5]
Phenobarbital	DMXZOCG	Cluster headache	8A81.0	Approved	[6]
Piperazine	DMTY9LU	Ascariasis	1F62	Approved	[7]
THIOCOLCHICOSIDE	DMEPWYA	Muscle spasm	MB47.3	Approved	[8]

8 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ANDROSTERONE	DMITJAK	N. A.	N. A.	Phase 3	[2]
ZK-93423	DMFWMKZ	Epileptic seizures	8A61-8A6Z	Phase 3	[9]
BL-1020	DMVDO93	Schizophrenia	6A20	Phase 2	[10]
BNC-210	DMEGDWA	Anxiety disorder	6B00-6B0Z	Phase 2	[11]
Dextofisopam	DM9L15R	Irritable bowel syndrome	DD91.0	Phase 2	[12]
GSK683699	DMTW79H	Inflammatory bowel disease	DD72	Phase 2	[8]
Phenylbutyrate	DMBHPDW	Urea cycle disorder	5C50.A	Phase 2	[13]
PIKAMILONE	DMAFZ84	Anxiety disorder	6B00-6B0Z	Phase 2	[14]

10 Discontinued Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ELTANOLONE	DM38CIV	Premenstrual syndrome	GA34.40	Discontinued in Phase 3	[2]
Dezinamide	DMJT8Q0	Epileptic seizures	8A61-8A6Z	Discontinued in Phase 2	[15]
Gedocarnil	DMNFWR1	Anxiety disorder	6B00-6B0Z	Discontinued in Phase 1	[16]
U-78875	DM2WOPX	Anxiety disorder	6B00-6B0Z	Discontinued in Phase 1	[17]
C-202	DMPL0C9	Epilepsy	8A60-8A68	Terminated	[18]
CGS-17867A	DMMZJY3	Alcohol dependence	6C40.2	Terminated	[19]
CGS-9896	DM39PQI	N. A.	N. A.	Terminated	[20]
Divaplon	DMO3XBP	N. A.	N. A.	Terminated	[21]
U-90042	DMTMZJ4	Anxiety disorder	6B00-6B0Z	Terminated	[22]
XR-368	DMX0PTO	Anxiety disorder	6B00-6B0Z	Terminated	[23]

206 Investigative Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
((E)-3-Amino-propenyl)-methyl-phosphinic acid	DMEJRVW	Discovery agent	N.A.	Investigative	[24]
(2-Amino-4,5-dihydro-thiazol-4-yl)-acetic acid	DMLEZKJ	Discovery agent	N.A.	Investigative	[25]
(2E,4S)-4-ammoniopent-2-enoate	DMA9RIS	Discovery agent	N.A.	Investigative	[26]
(4R)-4-ammoniopentanoate	DMZFTI4	Discovery agent	N.A.	Investigative	[26]
(4S)-4-ammoniopentanoate	DMBLAY1	Discovery agent	N.A.	Investigative	[26]
(6-Benzylamino-9H-beta-carbolin-3-yl)-methanol	DMAXS9H	Discovery agent	N.A.	Investigative	[27]
(9-Benzyl-9H-purin-6-yl)-cyclopropyl-amine	DMHJG5N	Discovery agent	N.A.	Investigative	[28]
(9H-beta-Carbolin-3-yl)-carbamic acid ethyl ester	DMKI2Y9	Discovery agent	N.A.	Investigative	[29]
(9H-beta-Carbolin-3-yl)-ethyl-amine	DMVHMPC	Discovery agent	N.A.	Investigative	[29]
(9H-beta-Carbolin-3-yl)-methanol	DMUF16A	Discovery agent	N.A.	Investigative	[27]
(beta-CCE)9H-beta-Carboline-3-carboxylic acid	DMVWQ26	Discovery agent	N.A.	Investigative	[30]
(R)-4-amino-2-methylbutanoic acid	DM3F56O	Discovery agent	N.A.	Investigative	[31]
1,1-Dimethyl-5-oxa-spiro[2.4]heptan-4-one	DMOGHRS	Discovery agent	N.A.	Investigative	[32]
1,3-Diphenyl-1H-chromeno[4,3-c]pyrazol-4-one	DM1KND6	Discovery agent	N.A.	Investigative	[33]
1-(4-chlorophenyl)-4-phenyl-1H-imidazole	DMVCHSI	Discovery agent	N.A.	Investigative	[20]
1-(9H-beta-Carbolin-3-yl)-butan-1-one	DMA96U5	Discovery agent	N.A.	Investigative	[34]
1-(9H-beta-Carbolin-3-yl)-ethanone	DMFOD2L	Discovery agent	N.A.	Investigative	[27]
1-Methyl-5-oxa-spiro[2.4]heptan-4-one	DMX2FWN	Discovery agent	N.A.	Investigative	[32]
2,4-Diamino-butyric acid(GABA)	DMAOGBP	Discovery agent	N.A.	Investigative	[35]
2,6-Diisopropyl-4-nitro-phenol	DMD51I4	Discovery agent	N.A.	Investigative	[36]
2-(1H-Indol-3-yl)-2-oxo-N-phenethyl-acetamide	DMFAME4	Discovery agent	N.A.	Investigative	[30]
2-(2-Amino-phenyl)-6-methyl-chromen-4-one	DM0CWHT	Discovery agent	N.A.	Investigative	[37]
2-(2-Hydroxy-phenyl)-6-methyl-chromen-4-one	DMOANXP	Discovery agent	N.A.	Investigative	[37]
2-(2-Methoxy-phenyl)-6-methyl-chromen-4-one	DMPVCDN	Discovery agent	N.A.	Investigative	[37]
2-(3-Amino-phenyl)-6-methyl-chromen-4-one	DMAP37I	Discovery agent	N.A.	Investigative	[37]
2-(3-Bromo-phenyl)-6-methyl-chromen-4-one	DM9G7B6	Discovery agent	N.A.	Investigative	[37]
2-(3-Bromo-phenyl)-6-nitro-chromen-4-one	DM9RAYC	Discovery agent	N.A.	Investigative	[38]
2-(3-Bromo-phenyl)-chromen-4-one	DM7XDLO	Discovery agent	N.A.	Investigative	[38]
2-(3-Butoxy-phenyl)-6-methyl-chromen-4-one	DMSZT9G	Discovery agent	N.A.	Investigative	[37]
2-(3-Chloro-phenyl)-chromen-4-one	DML83DM	Discovery agent	N.A.	Investigative	[38]
2-(3-Hydroxy-phenyl)-6-methyl-chromen-4-one	DM40RS3	Discovery agent	N.A.	Investigative	[37]
2-(3-Methoxy-phenyl)-6-methyl-chromen-4-one	DMBGVEK	Discovery agent	N.A.	Investigative	[37]
2-(4-Amino-phenyl)-6-methyl-chromen-4-one	DMGQHBU	Discovery agent	N.A.	Investigative	[37]
2-(4-Chloro-phenyl)-3H-imidazo[4,5-c]quinoline	DMSB0JA	Discovery agent	N.A.	Investigative	[39]
2-(4-chlorophenyl)-5-phenyl-4-isoxazolin-3-one	DMYGRS9	Discovery agent	N.A.	Investigative	[20]
2-(9-Benzyl-9H-purin-6-ylamino)-ethanol	DMPJ0O6	Discovery agent	N.A.	Investigative	[28]
2-Furan-2-yl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMHT80R	Discovery agent	N.A.	Investigative	[40]
2-Isoxazol-3-yl-3H-imidazo[4,5-c]quinoline	DM1F4TN	Discovery agent	N.A.	Investigative	[39]
2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline	DMD2ZNA	Discovery agent	N.A.	Investigative	[39]
2-Oxa-spiro[4.4]nonan-1-one	DM2NEX4	Discovery agent	N.A.	Investigative	[32]
2-p-Tolyl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMJIVL3	Discovery agent	N.A.	Investigative	[40]
2-Phenyl-3H-imidazo[4,5-c]quinoline	DML9DJP	Discovery agent	N.A.	Investigative	[39]
2-Phenyl-5,6-dihydro-pyrazolo[1,5-c]quinazoline	DMUIYZB	Discovery agent	N.A.	Investigative	[40]
2-Phenyl-6-propyl-chromen-4-one	DMY9ERA	Discovery agent	N.A.	Investigative	[37]
2-Phenyl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMA1RHE	Discovery agent	N.A.	Investigative	[40]
2-Pyridin-2-yl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMLCDZN	Discovery agent	N.A.	Investigative	[40]
2-Thiophen-2-yl-3H-imidazo[4,5-c]quinoline	DMPF598	Discovery agent	N.A.	Investigative	[39]
3,3-Diethyl-dihydro-furan-2-one	DMFJ9N0	Discovery agent	N.A.	Investigative	[32]
3,3-Diisopropyl-dihydro-furan-2-one	DMIFUDG	Discovery agent	N.A.	Investigative	[32]
3,3-Dimethyl-dihydro-furan-2-one	DM09LY4	Discovery agent	N.A.	Investigative	[32]
3-(2,2-Dimethyl-propoxy)-9H-beta-carboline	DMSCIP2	Discovery agent	N.A.	Investigative	[34]
3-(3-Methyl-butoxy)-9H-beta-carboline	DMTNCXP	Discovery agent	N.A.	Investigative	[34]
3-(benzyloxy)-9H-pyrido[3,4-b]indole	DMDNEKR	Discovery agent	N.A.	Investigative	[41]
3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole	DMKHNTY	Discovery agent	N.A.	Investigative	[41]
3-amino-3-demethoxythiocolchicine	DM60K7H	Discovery agent	N.A.	Investigative	[8]
3-ammoniopropane-1-sulfinate	DM5SQVC	Discovery agent	N.A.	Investigative	[42]
3-Butoxy-9H-beta-carboline	DMQ8H74	Discovery agent	N.A.	Investigative	[34]
3-butoxycarbonyl-4-quinolone	DMRF2Q8	Discovery agent	N.A.	Investigative	[43]
3-butoxycarbonyl-6-ethyl-4-quinolone	DMD6PMZ	Discovery agent	N.A.	Investigative	[43]
3-butylaminocarbonyl-6-ethyl-4-quinolone	DM95XWR	Discovery agent	N.A.	Investigative	[43]
3-carboxy-6-ethyl-4-quinolone	DMRUX93	Discovery agent	N.A.	Investigative	[43]
3-Chloro-9H-beta-carboline	DMCD901	Discovery agent	N.A.	Investigative	[44]
3-cyclopentoxycarbonyl-6-ethyl-4-quinolone	DMEL8S5	Discovery agent	N.A.	Investigative	[43]
3-demethoxy-3-D-lyxopyranosylaminothiocolchicine	DME8VPC	Discovery agent	N.A.	Investigative	[8]
3-demethoxy-3-D-mannopyranosylaminothiocolchicine	DMALMGH	Discovery agent	N.A.	Investigative	[8]
3-demethoxy-3-D-xylopyranosylaminothiocolchicine	DMXFVD1	Discovery agent	N.A.	Investigative	[8]
3-demethoxy-3-L-fucopyranosylaminothiocolchicine	DM4ERYF	Discovery agent	N.A.	Investigative	[8]
3-demethoxy-3D-glucopyranosylaminothiocolchicine	DMID7TC	Discovery agent	N.A.	Investigative	[8]
3-Ethoxy-9H-beta-carboline	DM6K7BI	Discovery agent	N.A.	Investigative	[45]
3-ethoxycarbonyl-4-quinolone	DMY4VOI	Discovery agent	N.A.	Investigative	[43]
3-ethoxycarbonyl-6-ethyl-2-methyl-4-quinolone	DMMDOI4	Discovery agent	N.A.	Investigative	[43]
3-ethoxycarbonyl-6-propyl-4-quinolone	DM1E5QZ	Discovery agent	N.A.	Investigative	[43]
3-Ethyl-3-isopropyl-dihydro-furan-2-one	DMZK13I	Discovery agent	N.A.	Investigative	[32]
3-Ethyl-3-methyl-dihydro-furan-2-one	DM1VTFU	Discovery agent	N.A.	Investigative	[32]
3-Hydroxy-piperidine-4-carboxylic acid	DM5OR96	Discovery agent	N.A.	Investigative	[46]
3-Isobutoxy-9H-beta-carboline	DM6X5TZ	Discovery agent	N.A.	Investigative	[34]
3-Isopropoxy-9H-beta-carboline	DM7PHO4	Discovery agent	N.A.	Investigative	[34]
3-Isopropyl-3-methyl-dihydro-furan-2-one	DMSLPGZ	Discovery agent	N.A.	Investigative	[32]
3-Isothiocyanato-9H-beta-carboline	DM9LEWH	Discovery agent	N.A.	Investigative	[47]
3-Methoxy-9H-beta-carboline	DMTBX0D	Discovery agent	N.A.	Investigative	[44]
3-Methoxycarbonyl-2-methyl-9H-beta-carbolin-2-ium	DMQMT1A	Discovery agent	N.A.	Investigative	[48]
3-Methyl-1-phenyl-1H-chromeno[4,3-c]pyrazol-4-one	DMTM6B0	Discovery agent	N.A.	Investigative	[33]
3-Methyl-2-phenyl-2H-chromeno[4,3-c]pyrazol-4-one	DM870UV	Discovery agent	N.A.	Investigative	[33]
3-Methyl-9H-beta-carboline	DMEJKZN	Discovery agent	N.A.	Investigative	[49]
3-Nitro-9H-beta-carboline	DM08V9W	Discovery agent	N.A.	Investigative	[44]
3-Propoxy-9H-beta-carboline	DMDEV64	Discovery agent	N.A.	Investigative	[44]
3-sec-Butoxy-9H-beta-carboline	DMNP8DQ	Discovery agent	N.A.	Investigative	[34]
3-tert-Butyl-3-ethyl-dihydro-furan-2-one	DMGDT8V	Discovery agent	N.A.	Investigative	[32]
4-(2-aminoethyl)-1,2,5-oxadiazol-3-ol	DMCS538	Discovery agent	N.A.	Investigative	[50]
4-(4-chlorophenyl)-1-pyrid-2-yl-pyrazole	DMJI6QH	Discovery agent	N.A.	Investigative	[20]
4-(5-tert-Butyl-[1,3]dithian-2-yl)-benzonitrile	DMZ1DW0	Discovery agent	N.A.	Investigative	[51]
4-Amino-3-hydroxy-butyric acid	DMPY8D3	Discovery agent	N.A.	Investigative	[52]
4-benzyl-5-(4-piperidyl)isothiazol-3-ol	DMZ18OJ	Discovery agent	N.A.	Investigative	[53]
4-Benzyl-5-piperidin-4-yl-isoxazol-3-ol	DMA4CZK	Discovery agent	N.A.	Investigative	[54]
4-Bromo-2,6-diisopropyl-phenol	DMY8TLO	Discovery agent	N.A.	Investigative	[36]
4-Chloro-2,6-diisopropyl-phenol	DM9VN21	Discovery agent	N.A.	Investigative	[36]
4-Dimethylamino-2,6-diisopropyl-phenol	DMEC1PS	Discovery agent	N.A.	Investigative	[36]
4-Ethyl-5-piperidin-4-yl-isoxazol-3-ol	DMYO2GP	Discovery agent	N.A.	Investigative	[55]
4-Hydroxy-3,5-diisopropyl-benzaldehyde	DM2PS89	Discovery agent	N.A.	Investigative	[36]
4-Iodo-2,6-diisopropyl-phenol	DMIPENJ	Discovery agent	N.A.	Investigative	[36]
4-Methoxymethyl-3,6-dipropoxy-9H-beta-carboline	DMCS83F	Discovery agent	N.A.	Investigative	[45]
4-Methyl-5-(4-piperidyl)isothiazol-3-ol	DMV19HC	Discovery agent	N.A.	Investigative	[53]
4-Methyl-5-piperidin-4-yl-isoxazol-3-ol	DM0ZA7T	Discovery agent	N.A.	Investigative	[55]
4-Naphthalen-1-yl-5-piperidin-4-yl-isoxazol-3-ol	DMEIA3L	Discovery agent	N.A.	Investigative	[54]
4-Naphthalen-2-yl-5-piperidin-4-yl-isoxazol-3-ol	DM9O8UM	Discovery agent	N.A.	Investigative	[54]
4-Phenyl-5-piperidin-4-yl-isoxazol-3-ol	DM7E4JU	Discovery agent	N.A.	Investigative	[56]
5-(4-piperidyl)-4-propylisothiazol-3-ol	DMZ7K5G	Discovery agent	N.A.	Investigative	[53]
5-(piperidin-4-yl)isothiazol-3-ol	DM4XGFW	Discovery agent	N.A.	Investigative	[53]
5-(piperidin-4-yl)isoxazol-3-ol	DM6GO2I	Discovery agent	N.A.	Investigative	[56]
5-Aminomethyl-4,5-dihydro-isoxazol-3-ol	DMZK8V5	Discovery agent	N.A.	Investigative	[52]
5-tert-Butyl-2-(4-ethynyl-phenyl)-[1,3]dithiane	DMCG6EK	Discovery agent	N.A.	Investigative	[51]
5-tert-Butyl-2-(4-fluoro-phenyl)-[1,3]dithiane	DMQK32F	Discovery agent	N.A.	Investigative	[51]
5-[(1R)-1-ammonioethyl]isoxazol-3-olate	DM23PL4	Discovery agent	N.A.	Investigative	[26]
5-[(1S)-1-ammonioethyl]isoxazol-3-olate	DMYAPLT	Discovery agent	N.A.	Investigative	[26]
6,6-Dimethyl-2-oxa-spiro[4.4]nonan-1-one	DMOIFAP	Discovery agent	N.A.	Investigative	[32]
6,9-Dimethyl-2-oxa-spiro[4.4]nonan-1-one	DM7FMWS	Discovery agent	N.A.	Investigative	[32]
6-benzyl-3-ethoxycarbonyl-4-quinolone	DMICRFQ	Discovery agent	N.A.	Investigative	[43]
6-benzyl-3-propoxycarbonyl-4-quinolone	DMXMI5E	Discovery agent	N.A.	Investigative	[43]
6-benzyl-3-propylaminocarbonyl-4-quinolone	DM7HNPJ	Discovery agent	N.A.	Investigative	[43]
6-Bromo-2-(2-nitro-phenyl)-chromen-4-one	DM7U58O	Discovery agent	N.A.	Investigative	[57]
6-Bromo-2-(3-bromo-phenyl)-chromen-4-one	DMTJRF3	Discovery agent	N.A.	Investigative	[38]
6-Bromo-2-(3-nitro-phenyl)-chromen-4-one	DMP8ZVS	Discovery agent	N.A.	Investigative	[57]
6-Bromo-2-(4-nitro-phenyl)-chromen-4-one	DMCX3TM	Discovery agent	N.A.	Investigative	[57]
6-Bromo-2-phenyl-chromen-4-one	DMMCNQI	Discovery agent	N.A.	Investigative	[38]
6-bromo-3-ethoxycarbonyl-2-methyl-4-quinolone	DM4HRIX	Discovery agent	N.A.	Investigative	[43]
6-bromo-3-ethoxycarbonyl-4-quinolone	DM0MQHP	Discovery agent	N.A.	Investigative	[43]
6-Chloro-2-(3-nitro-phenyl)-chromen-4-one	DMTWBOV	Discovery agent	N.A.	Investigative	[38]
6-Chloro-2-phenyl-chromen-4-one	DM5FZDI	Discovery agent	N.A.	Investigative	[38]
6-Ethyl-2-phenyl-chromen-4-one	DMUHOF4	Discovery agent	N.A.	Investigative	[37]
6-ethyl-3-(2-ethylbutoxycarbonyl)-4-quinolone	DMLEUP2	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-(2-methylbutoxycarbonyl)-4-quinolone	DMESU53	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-(3-methylbutoxycarbonyl)-4-quinolone	DM1POEA	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-(3-pentoxycarbonyl)-4-quinolone	DMG05V1	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-i-propoxycarbonyl-4-quinolone	DML9EU7	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-pentoxycarbonyl-4-quinolone	DMSGJM6	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-propoxycarbonyl-4-quinolone	DMGVI08	Discovery agent	N.A.	Investigative	[43]
6-ethyl-3-propylaminocarbonyl-4-quinolone	DMC1F2E	Discovery agent	N.A.	Investigative	[43]
6-Fluoro-2-(3-nitro-phenyl)-chromen-4-one	DMPZIV0	Discovery agent	N.A.	Investigative	[38]
6-Isopropyl-2-phenyl-chromen-4-one	DMO2F8L	Discovery agent	N.A.	Investigative	[37]
6-Methyl-2-oxa-spiro[4.4]nonan-1-one	DMNJRFP	Discovery agent	N.A.	Investigative	[32]
6-Methyl-2-p-tolyl-chromen-4-one	DM8KMEG	Discovery agent	N.A.	Investigative	[37]
6-Methyl-2-phenyl-chromen-4-one	DMAXBOU	Discovery agent	N.A.	Investigative	[37]
6-Methyl-2-pyridin-3-yl-chromen-4-one	DMFMK6Y	Discovery agent	N.A.	Investigative	[37]
6-Nitro-2-(3-nitro-phenyl)-chromen-4-one	DMRCTBA	Discovery agent	N.A.	Investigative	[58]
6-Nitro-2-(4-nitro-phenyl)-chromen-4-one	DMM635K	Discovery agent	N.A.	Investigative	[58]
6-Nitro-2-phenyl-chromen-4-one	DMVLID9	Discovery agent	N.A.	Investigative	[38]
7,12-Dihydro-5,7,12-triaza-indeno[1,2-a]fluorene	DM3FXRC	Discovery agent	N.A.	Investigative	[59]
7,12-Dihydro-7,12-diaza-indeno[1,2-a]fluorene	DMTZ943	Discovery agent	N.A.	Investigative	[44]
7-Diazonium-naphthalene-1-sulfonic acid anion	DMANYSO	Discovery agent	N.A.	Investigative	[60]
8-Diazonium-naphthalene-1-sulfonic acid anion	DMQJA4F	Discovery agent	N.A.	Investigative	[60]
9H-beta-Carbolin-3-ol	DMBWAMR	Discovery agent	N.A.	Investigative	[44]
9H-beta-Carbolin-6-ylamine	DMBLEI7	Discovery agent	N.A.	Investigative	[27]
9H-beta-Carboline-3-carboxylic acid ethyl ester	DMK459I	Discovery agent	N.A.	Investigative	[41]
9H-beta-Carboline-3-carboxylic acid propyl ester	DMMUH98	Discovery agent	N.A.	Investigative	[61]
Acetic acid 2,6-diisopropyl-phenyl ester	DMBP5L4	Discovery agent	N.A.	Investigative	[36]
AFLATREME	DM2R5F9	Discovery agent	N.A.	Investigative	[62]
ALFAXALONE	DMI4OTW	Discovery agent	N.A.	Investigative	[36]
AMENTOFLAVONE	DMLRNV2	Discovery agent	N.A.	Investigative	[63]
Benzoic acid 2,6-diisopropyl-phenyl ester	DMAQK0G	Discovery agent	N.A.	Investigative	[36]
Benzyl-(9H-beta-carbolin-6-yl)-amine	DMW167A	Discovery agent	N.A.	Investigative	[44]
Beta-Carboline-3-carboxylic acid t-butyl ester	DM9LT60	N. A.	N. A.	Investigative	[41]
BETA-CCM	DM1MFTZ	Discovery agent	N.A.	Investigative	[64]
Bicuculline	DMA6VQW	Discovery agent	N.A.	Investigative	[65]
BRL-54504AX	DM2J1FA	Discovery agent	N.A.	Investigative	[66]
CGS-13767	DM4DSE7	Discovery agent	N.A.	Investigative	[67]
CGS-9895	DMKY6CU	Discovery agent	N.A.	Investigative	[68]
CI-218872	DM0RH3S	Discovery agent	N.A.	Investigative	[41]
Ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate	DM5G91Z	Discovery agent	N.A.	Investigative	[41]
ETIOCHOLANOLONE	DMVI9DM	Discovery agent	N.A.	Investigative	[2]
flavone	DMEQH6J	Discovery agent	N.A.	Investigative	[37]
GNF-PF-3645	DM17GIV	Discovery agent	N.A.	Investigative	[43]
GNF-PF-4421	DMV10UH	Discovery agent	N.A.	Investigative	[43]
isonipecotic acid	DMO1ZHE	Discovery agent	N.A.	Investigative	[46]
Isoquinoline-3-carboxylic acid methyl ester	DMWIMUZ	Discovery agent	N.A.	Investigative	[44]
L-655708	DM4CDIB	Discovery agent	N.A.	Investigative	[69]
Muscimol	DMNTF2O	Discovery agent	N.A.	Investigative	[70]
N-(9H-beta-Carbolin-3-yl)-acetamide	DMBD52I	Discovery agent	N.A.	Investigative	[29]
N-(9H-beta-Carbolin-3-yl)-formamide	DM3KNSY	Discovery agent	N.A.	Investigative	[29]
N-Benzyl-2-(1H-indol-3-yl)-2-oxo-acetamide	DM8A23B	Discovery agent	N.A.	Investigative	[71]
N-butyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide	DMH7Z4L	Discovery agent	N.A.	Investigative	[72]
N-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide	DM8ZMB5	Discovery agent	N.A.	Investigative	[73]
NIPECOTIC ACID	DMPV450	Discovery agent	N.A.	Investigative	[74]
NORHARMANE	DMKYQWG	Discovery agent	N.A.	Investigative	[44]
NSC-73613	DMT6CV5	Discovery agent	N.A.	Investigative	[38]
NSC-93394	DM2JPD4	Discovery agent	N.A.	Investigative	[38]
Pitrazepine	DMKHZQW	Discovery agent	N.A.	Investigative	[75]
Pyrrolidin-3-yl-acetic acid	DM0BHCJ	Discovery agent	N.A.	Investigative	[74]
Ridine-5-carboxylic acid ethyl ester	DM9HMCS	Discovery agent	N.A.	Investigative	[76]
RIPAZEPAM	DMTHVQD	Discovery agent	N.A.	Investigative	[77]
RO-054520	DM78B4A	Discovery agent	N.A.	Investigative	[78]
RO-145974	DM0ACKJ	Discovery agent	N.A.	Investigative	[79]
RO-145975	DMAJ6BW	Discovery agent	N.A.	Investigative	[79]
RO-147437	DMX4B36	Discovery agent	N.A.	Investigative	[79]
Ro-15-3505	DM4NW3U	Discovery agent	N.A.	Investigative	[80]
RO-194603	DM8C2Z0	Discovery agent	N.A.	Investigative	[79]
Ro-4938581	DMCB2N9	Discovery agent	N.A.	Investigative	[81]
RWJ-16979	DME68VT	Discovery agent	N.A.	Investigative	[82]
RY-066	DMGUX16	Discovery agent	N.A.	Investigative	[83]
Sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate	DM9QSDC	Discovery agent	N.A.	Investigative	[41]
SR95531	DMA28ZX	N. A.	N. A.	Investigative	[65]
Toluene-1-diazonium-3-sulfonic acid anion	DMAYUV6	Discovery agent	N.A.	Investigative	[60]
U-89267	DMQT6AH	Discovery agent	N.A.	Investigative	[84]
WEDELOLACTONE	DMHL3YV	Discovery agent	N.A.	Investigative	[85]
[3H]CGP27492	DMQTBRM	Discovery agent	N.A.	Investigative	[86]
[3H]CGS8216	DMLP68J	Inflammation	1A00-CA43.1	Investigative	[67]
[3H]Ro154513	DMMBWKL	Discovery agent	N.A.	Investigative	[87]

References

• [1] Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17.
• [2] Neurosteroid analogues. 11. Alternative ring system scaffolds: gamma-aminobutyric acid receptor modulation and anesthetic actions of benz[f]indenes. J Med Chem. 2006 Jul 27;49(15):4595-605.
• [3] Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new se... J Med Chem. 1997 Sep 12;40(19):3109-18.
• [4] DP-VPA D-Pharm. Curr Opin Investig Drugs. 2002 Jun;3(6):921-3.
• [5] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
• [6] DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6.
• [7] Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003 Sep;22(3):318-31.
• [8] 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds. J Med Chem. 2006 Sep 7;49(18):5571-7.
• [9] Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carbolin... J Med Chem. 1990 Mar;33(3):1062-9.
• [10] The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
• [11] 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov. 2013 Sep;12(9):667-87.
• [12] Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.
• [13] Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52.
• [14] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [15] Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs. Epilepsia. 1995;36 Suppl 2:S105-14.
• [16] US patent application no. US20040102438 A1.
• [17] Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality. J Med Chem. 1999 Apr 8;42(7):1123-44.
• [18] Capreomycin Binds across the Ribosomal Subunit Interface Using tlyA-Encoded 2 O-Methylations in 16S and 23S rRNAs. Molecular Cell Volume 23, Issue 2, 21 July 2006, Pages 173-182.
• [19] 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3441-4.
• [20] Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors. J Med Chem. 2006 Mar 23;49(6):1855-66.
• [21] (Imidazo[1,2-a]pyrimidin-2-yl)phenylmethanones and related compounds as potential nonsedative anxiolytics. J Med Chem. 1988 Jun;31(6):1220-6.
• [22] U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes. J Pharmacol Exp Ther. 1995 Nov;275(2):761-7.
• [23] Regulation of neuronal and recombinant GABA(A) receptor ion channels by xenovulene A, a natural product isolated from Acremonium strictum. J Pharmacol Exp Ther. 1997 Aug;282(2):513-20.
• [24] Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships. J Med Chem. 2008 Jul 10;51(13):3825-40.
• [25] ( )-2-amino-2-thiazoline-4-ethanoic acid; a novel, specific GABAA receptor agonist. Bioorg. Med. Chem. Lett. 1(5):247-248 (1991).
• [26] gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J Med Chem. 1981 Dec;24(12):1377-83.
• [27] Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists. J Med Chem. 1987 Apr;30(4):750-3.
• [28] Benzodiazepine receptor binding activity of 6,9-disubstituted purines. J Med Chem. 1989 May;32(5):1020-4.
• [29] 3-Amino-beta-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam. J Med Chem. 1985 Jun;28(6):824-8.
• [30] Benzodiazepine receptor affinity and interaction of some N-(indol-3-ylglyoxylyl)amine derivatives. J Med Chem. 1992 Jun 12;35(12):2214-20.
• [31] Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA(C) receptors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):402-4.
• [32] Alpha-spirocyclopentyl- and alpha-spirocyclopropyl-gamma-butyrolactones: conformationally constrained derivatives of anticonvulsant and convulsant ... J Med Chem. 1994 Jan 21;37(2):275-86.
• [33] Synthesis, binding studies, and structure-activity relationships of 1-aryl-and 2-aryl[1]benzopyranopyrazol-4-ones, central benzodiazepine receptor ... J Med Chem. 1988 Jan;31(1):1-3.
• [34] Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach. J Med Chem. 1992 Oct 30;35(22):4001-10.
• [35] Glycine antagonists. Synthesis, structure, and biological effects of some bicyclic 5-isoxazolol zwitterions. J Med Chem. 1986 Feb;29(2):224-9.
• [36] Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological p... J Med Chem. 1998 May 21;41(11):1846-54.
• [37] Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor. J Med Chem. 2002 Sep 12;45(19):4188-201.
• [38] Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor, Bioorg. Med. Chem. Lett. 7(15):2003-2008 (1997).
• [39] Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. J Med Chem. 1996 Jul 5;39(14):2844-51.
• [40] Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. J Med Chem. 1996 Jul 19;39(15):2915-21.
• [41] Design, synthesis, and subtype selectivity of 3,6-disubstituted -carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents f... Bioorg Med Chem. 2010 Nov 1;18(21):7548-64.
• [42] A study of 3-amino-N-hydroxypropanesulfonamide derivatives as potential GABAB agonists and their fragmentation to 3-aminopropanesulfinic acid, Bioorg. Med. Chem. Lett. 6(14):1709-1714 (1996).
• [43] 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore mod... J Med Chem. 2006 Apr 20;49(8):2526-33.
• [44] Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore. J Med Chem. 1988 Sep;31(9):1854-61.
• [45] Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) a... J Med Chem. 1998 Jul 2;41(14):2537-52.
• [46] Hydroxy- and amino-substituted piperidinecarboxylic acids as gamma-aminobutyric acid agonists and uptake inhibitors. J Med Chem. 1982 Oct;25(10):1157-62.
• [47] Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. J Med Chem. 1990 Sep;33(9):2343-57.
• [48] N-2 methylated quaternary derivatives of beta-carboline-3-carboxylates inhibit acetylcholinesterase in vitroO, Bioorg. Med. Chem. Lett. 3(12):2831-2836 (1993).
• [49] Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. J Med Chem. 1994 Dec 23;37(26):4576-80.
• [50] Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and pharmacological characterization of ga... J Med Chem. 2006 Jul 13;49(14):4442-6.
• [51] Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dith... J Med Chem. 1995 Jul 7;38(14):2663-71.
• [52] GABA agonists. Resolution, absolute stereochemistry, and enantioselectivity of (S)-(+)- and (R)-(-)-dihydromuscimol. J Med Chem. 1985 Nov;28(11):1612-7.
• [53] Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology. J Med Chem. 2006 Feb 23;49(4):1388-96.
• [54] Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. J Med Chem. 2005 Jan 27;48(2):427-39.
• [55] A novel class of potent 3-isoxazolol GABA(A) antagonists: design, synthesis, and pharmacology. J Med Chem. 2000 Dec 28;43(26):4930-3.
• [56] 4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships. J Med Chem. 2007 Apr 19;50(8):1988-92.
• [57] 6-Bromo-3 nitroflavone, a new high affinity benzodiazepine receptor agonist recognizes two populations of cerebral cortical binding sites, Bioorg. Med. Chem. Lett. 7(3):373-378 (1997).
• [58] 6,3'-Dinitroflavone, a novel high affinity ligand for the benzodiazepine receptor with potent anxiolytic properties, Bioorg. Med. Chem. Lett. 5(22):2717-2720 (1995).
• [59] Synthesis of 7,12-dihydropyrido[3,4-b:5,4-b']diindoles. A novel class of rigid, planar benzodiazepine receptor ligands. J Med Chem. 1987 Mar;30(3):456-8.
• [60] Aryl diazo compounds and diazonium salts as potential irreversible probes of the gamma-aminobutyric acid receptor. J Med Chem. 1987 Dec;30(12):2222-7.
• [61] beta-Carbolines as benzodiazepine receptor ligands. 1. Synthesis and benzodiazepine receptor interaction of esters of beta-carboline-3-carboxylic a... J Med Chem. 1983 Apr;26(4):499-503.
• [62] Partial structures of the fungal toxin aflatrem, methyl-substituted 6,8-dioxabicyclo[3.2.1]octan-2-ones have anticonvulsant activity, Bioorg. Med. Chem. Lett. 5(3):265-270 (1995).
• [63] Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4.
• [64] Synthetic routes to 4-amino-3-carboxy-beta-carboline derivatives: incidental formation of novel furo[3,4-c]-beta-carbolin-2-ones displaying high af... J Med Chem. 1995 Jan 6;38(1):189-98.
• [65] GABA receptors inhibited by benzodiazepines mediate fast inhibitory transmission in the central amygdala. J Neurosci. 1999 Nov 15;19(22):9698-704.
• [66] Isosteric replacement of the indole nucleus by benzothiophene in a series of pyrido[2,3-b]indoles with potential anxiolytic activity, Bioorg. Med. Chem. Lett. 5(22):2589-2592 (1995).
• [67] Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones. J Med Chem. 1991 Jan;34(1):281-90.
• [68] 1,3-Diarylpyrazolo[4,5-c]- and -[5,4-c]quinolin-4-ones. 4. Synthesis and specific inhibition of benzodiazepine receptor binding. J Med Chem. 1987 Oct;30(10):1737-42.
• [69] 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor li... J Med Chem. 2004 Mar 25;47(7):1807-22.
• [70] THIP treatment of Huntington's disease. Neurology. 1983 May;33(5):637-9.
• [71] N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological acti... J Med Chem. 1998 Sep 24;41(20):3821-30.
• [72] Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-... J Med Chem. 2007 Apr 5;50(7):1627-34.
• [73] Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular mo... J Med Chem. 2001 Jul 5;44(14):2286-97.
• [74] Orally active and potent inhibitors of gamma-aminobutyric acid uptake. J Med Chem. 1985 May;28(5):653-60.
• [75] Structure and molecular modeling of GABAA receptor antagonists. J Med Chem. 1992 May 29;35(11):1969-77.
• [76] Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents. J Med Chem. 1989 Dec;32(12):2561-73.
• [77] Synthesis and interaction of 5-(substituted-phenyl)-3-methyl-6,7-dihydropyrazolo[4,3-e] [1,4]diazepin-8(7H)-ones with benzodiazepine receptors in r... J Med Chem. 1985 May;28(5):683-5.
• [78] Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem. 1988 Dec;31(12):2235-46.
• [79] Synthesis and evaluation of imidazo[1,5-a][1,4]benzodiazepine esters with high affinities and selectivities at "diazepam-insensitive" benzodiazepin... J Med Chem. 1993 Apr 16;36(8):1001-6.
• [80] The GABA(A) receptor as a target for photochromic molecules. Bioorg Med Chem. 2010 Nov 15;18(22):7731-8.
• [81] The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment... Bioorg Med Chem Lett. 2009 Oct 15;19(20):5940-4.
• [82] Potential anxiolytic agents. Pyrido[1,2-a]benzimidazoles: a new structural class of ligands for the benzodiazepine binding site on GABA-A receptors. J Med Chem. 1995 Jan 6;38(1):16-20.
• [83] Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines a... J Med Chem. 1998 Oct 8;41(21):4130-42.
• [84] Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptor. J Med Chem. 1994 Mar 18;37(6):758-68.
• [85] Synthesis and preliminary pharmacological evaluation of coumestans with different patterns of oxygenation. Bioorg Med Chem Lett. 2001 Feb 12;11(3):283-6.
• [86] Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J Med Chem. 1995 Aug 18;38(17):3297-312.
• [87] Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABA... J Med Chem. 1996 Apr 26;39(9):1928-34.